Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)
Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 0093-3420
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 0093-3420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label-5mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 2)
This text is describing a medication called Cyclobenzaprine Hydrochloride Tablets, USP. The medication comes in a bottle with an NDC code and a GIN code for identification. It is important to keep the medication out of reach of children and the adult dosage is provided. The tablet has the brand name "TaaPrums Fasbmn" and is manufactured by Teva. There are 100 tablets provided in the bottle, and there is a section for serialization coding.*
Label-7.5mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 3)
Label-10mg-100-tablets (Cyclobenzaprine HCl Tablets A071611 4)
This is a description of Cyclobenzaprine Hydrochloride Tablets, a prescription medication sold in bottles of 100. The National Drug Code (NDC) is 0093-3422-01, and the product is made by Teva. The text also contains a caution to keep the tablets out of reach of children, information about adult dosage and storage conditions, and a serial number for tracking purposes.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
